Astellas Venture Management

Astellas Venture Management

Astellas Venture Management

Suggest edits
Follow us
Also headquartered in Menlo Park
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 11

Portfolio

Portfolio Tracker

Add info
Cleave Biosciences

Cleave Biosciences

Biotechnology
Total funding
$81M in 2 rounds from 10 investors
By Astellas Venture Management
$37M Series B in Aug, 2016
Effector Therapeutics

Effector Therapeutics

Biotechnology
Total funding
$83.6M in 2 rounds from 14 investors
By Astellas Venture Management
$38.6M Series C in Jul, 2017
Fate Therapeutics Inc

Fate Therapeutics Inc

Biotechnology
Total funding
$58.3M in 3 rounds from 6 investors
By Astellas Venture Management
$36M Series B in May, 2011
Oncorus

Oncorus

Medical +2
Total funding
$84.5M in 2 rounds from 3 investors
By Astellas Venture Management
£4M Series A in Dec, 2016
Robert Gould

Robert Gould

Health and Wellness +1
Total funding
$43.5M in 3 rounds from 7 investors
By Astellas Venture Management
$32M Series B in Oct, 2009
Tizona Therapeutics

Tizona Therapeutics

Therapeutics
Total funding
$43M in 1 rounds from 7 investors
By Astellas Venture Management
$43M Series B in Mar, 2016
Twentyeight-Seven Therapeutics

Twentyeight-Seven Therapeutics

Biotechnology +1
Total funding
$15M in 1 rounds from 7 investors
By Astellas Venture Management
$15M Series A in May, 2019
Verastem

Verastem

United States
Total funding
$68M in 3 rounds from 6 investors
By Astellas Venture Management
$32M Series B in Jul, 2011

Want to see the complete list?
Go Pro!